New Clinical Trial Targets Parkinson’s Disease Before Motor Symptoms Emerge
Researchers have launched a clinical trial to investigate if an anti-inflammatory drug can delay or prevent Parkinson’s disease in people with a sleep behavior disorder.
Category: Parkinson’s Disease
Parkinson’s Disease
Latest
Parkinson’s Disease
Latest
DOD-Funded Research May Lead to Breakthroughs for Parkinson’s Symptom Management
Researchers have identified several medications that could be repurposed to treat serotonin dysfunction in Parkinson's Disease, should their hypothesis prove true.
Parkinson’s Disease
Latest
Research Reveals a Cause of Parkinson’s Disease
Researchers from the University of Copenhagen have unveiled new insights into the workings of the brain in Parkinson's patients, and a cause.
Parkinson’s Foundation Expands Global Care Network in the US
The Parkinson’s Foundation expands its Global Care Network with a membership program called Community Partners in Parkinson’s Care.
Read More
Are Climate Change and Air Pollution Making Neurologic Disease Worse?
People with neurologic diseases like headache, dementia, MS, and Parkinson’s disease may experience worsening symptoms due to climate change.
Read More
Parkinson’s Disease Incidence is 50% Higher Than Previous Estimates, Study Suggests
The annual incidence of Parkinson’s disease among older adults is 50% higher than current estimates of 60,000 diagnoses annually.
Read More
Protein Mutation That Causes Parkinson’s May Prevent Another Neurodegenerative Disease
A mutation in the misfolding protein that causes Parkinson’s offers protection against the neurodegenerative disease multiple system atrophy.
Read More
Parkinson’s Foundation and Tag.bio Partner to Accelerate Parkinson’s Research
The Parkinson’s Foundation and Tag.bio announce a partnership that will help accelerate research into the causes and treatment of PD.
Read More
Artificial Intelligence Helps Diagnose Parkinson’s
Researchers used artificial intelligence techniques to estimate parameters such as step length, width, and velocity to diagnose Parkinson’s.
Read More
Parkinson’s Foundation Launches New Online Education Series
Education Series for Community Providers is a six-part online education series offering PD information for medically underserved communities.
Read More
Parkinson’s Monitor App Parky Gets FDA Nod
The FDA-cleared Parky App monitors Parkinson’s symptoms such as tremors and dyskinesia in real time via the use of the Apple Watch.
Read More
NIH-Funded Parkinson’s Trial to Use Integrated Motion Analysis Suite
A second generation Integrated Motion Analysis Suite is being used as part of an NIH-funded trial investigating ESStim for Parkinson’s.
Read More
This Helps Improve Constipation in Parkinson’s Patients
ENT-01 is safe for up to 25 days of treatment and helps improve constipation and possibly neurological symptoms in Parkinson’s patients.
Read More
Esya Labs Receives $452K MJFF Grant to Develop Peripheral Markers for Parkinson’s Disease
Esya Labs will be partnering with MSD to validate peripheral biomarkers for Parkinson’s disease and accelerate therapeutics development.
Read More
Research Collaboration Forms to Study Parkinson’s Dementia
Enterin Inc and Parkinson’s Virtual Biotech, part of Parkinson’s UK, are collaborating to study ENT-01 effects on Parkinson’s dementia.
Read More
First World Movement Disorders Day: November 29
The International Parkinson and Movement Disorder Society (MDS) is launching the first World Movement Disorders Day on November 29, 2022.
Read More
Weight Changes in Early Parkinson’s May Be Tied to Changes in Thinking Skills
People with weight changes after Parkinson’s diagnosis may be more likely to have thinking skills changes than people who maintain weight.
Read More
CMS Sets Price for Cala TAPS Therapy for Essential Tremor
CMS’s decision expands access for Medicare patients with essential tremor who could benefit from Cala TAPS therapy.
Read More